MedTrace Logo

Diagnostic Value of Whole-Body MRI for Rectal Cancer Preoperative Staging

NCT01745874 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2012-12-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether whole-body MRI (WB-MRI) accuracy is superior to FDG-PET-CT considered as the gold-standard for the staging of distant lesions of rectal cancer.

Conditions

Sponsors & Collaborators

  • University of Lausanne Hospitals

    lead OTHER

Principal Investigators

  • Milena Cerny · University of Lausanne Hospitals

  • Sabine Schmidt Kobbe, Dr. · University of Lausanne Hospitals

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01745874 on ClinicalTrials.gov